Prudential Finl (PRU) Holder Palouse Capital Management Upped Stake; Accipiter Capital Management Increases Stake in Teva Pharm Adr (TEVA)

February 19, 2018 - By Adrian Mccoy

Gabe Hoffman increased its stake in Teva Pharm Adr (TEVA) by 198.89% based on its latest 2017Q3 regulatory filing with the SEC. Accipiter Capital Management Llc bought 402,040 shares as the company’s stock declined 15.11% while stock markets rallied. The hedge fund run by Gabe Hoffman held 604,185 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $10.63 million, up from 202,145 at the end of the previous reported quarter. Accipiter Capital Management Llc who had been investing in Teva Pharm Adr for a number of months, seems to be bullish on the $21.25 billion market cap company. The stock increased 0.43% or $0.09 during the last trading session, reaching $20.9. About 14.77M shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since February 19, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

Palouse Capital Management Inc increased its stake in Prudential Finl Inc (PRU) by 4.8% based on its latest 2017Q3 regulatory filing with the SEC. Palouse Capital Management Inc bought 3,964 shares as the company’s stock declined 6.41% while stock markets rallied. The institutional investor held 86,554 shares of the finance company at the end of 2017Q3, valued at $9.20M, up from 82,590 at the end of the previous reported quarter. Palouse Capital Management Inc who had been investing in Prudential Finl Inc for a number of months, seems to be bullish on the $46.48 billion market cap company. The stock decreased 0.27% or $0.3 during the last trading session, reaching $109.43. About 2.52M shares traded or 24.85% up from the average. Prudential Financial, Inc. (NYSE:PRU) has risen 33.66% since February 19, 2017 and is uptrending. It has outperformed by 16.96% the S&P500.

Investors sentiment decreased to 1 in Q3 2017. Its down 0.20, from 1.2 in 2017Q2. It is negative, as 43 investors sold PRU shares while 274 reduced holdings. 73 funds opened positions while 245 raised stakes. 265.93 million shares or 0.75% less from 267.93 million shares in 2017Q2 were reported. Davenport And Ltd Co accumulated 0% or 2,304 shares. Amf Pensionsforsakring Ab holds 0.64% or 547,878 shares in its portfolio. Kbc Nv stated it has 0.45% of its portfolio in Prudential Financial, Inc. (NYSE:PRU). Columbia L L C Mgmt has 0.03% invested in Prudential Financial, Inc. (NYSE:PRU) for 2,056 shares. 777,302 were reported by Alliancebernstein Ltd Partnership. Benin Management Corp stated it has 98,275 shares. Hbk Investments LP holds 0.07% or 85,900 shares. Amp Capital Limited invested in 319,739 shares or 0.19% of the stock. Twin Capital Mngmt, a Pennsylvania-based fund reported 27,425 shares. Moreover, Goldman Sachs Grp has 0.09% invested in Prudential Financial, Inc. (NYSE:PRU). Price T Rowe Assocs Inc Md holds 764,506 shares or 0.01% of its portfolio. Parsec accumulated 96,514 shares or 0.74% of the stock. Howe Rusling holds 53,325 shares or 1.05% of its portfolio. Buckingham Cap Mngmt Inc stated it has 18,708 shares or 0.44% of all its holdings. Thomas White Int Ltd holds 0.19% or 10,126 shares in its portfolio.

Among 15 analysts covering Prudential Financial (NYSE:PRU), 10 have Buy rating, 0 Sell and 5 Hold. Therefore 67% are positive. Prudential Financial had 50 analyst reports since August 6, 2015 according to SRatingsIntel. The company was upgraded on Tuesday, October 17 by Citigroup. Citigroup initiated Prudential Financial, Inc. (NYSE:PRU) on Thursday, January 26 with “Neutral” rating. Deutsche Bank upgraded Prudential Financial, Inc. (NYSE:PRU) on Monday, September 7 to “Buy” rating. The company was maintained on Monday, November 28 by FBR Capital. The stock of Prudential Financial, Inc. (NYSE:PRU) earned “Buy” rating by Keefe Bruyette & Woods on Friday, November 10. As per Wednesday, December 14, the company rating was downgraded by Morgan Stanley. The rating was upgraded by Bank of America on Friday, November 18 to “Buy”. Sandler O’Neill maintained the shares of PRU in report on Wednesday, January 10 with “Buy” rating. As per Tuesday, October 18, the company rating was downgraded by FBR Capital. Keefe Bruyette & Woods maintained the stock with “Buy” rating in Thursday, December 21 report.

Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 146 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Hold” rating by Piper Jaffray given on Thursday, August 3. The rating was downgraded by Argus Research on Tuesday, February 28 to “Hold”. The rating was downgraded by HSBC to “Reduce” on Tuesday, November 7. The rating was upgraded by Credit Suisse to “Neutral” on Friday, December 15. The rating was maintained by Leerink Swann on Friday, February 9 with “Underperform”. Deutsche Bank downgraded the stock to “Hold” rating in Friday, November 3 report. On Tuesday, September 5 the stock rating was downgraded by Credit Suisse to “Sell”. As per Friday, December 15, the company rating was maintained by RBC Capital Markets. The firm earned “Neutral” rating on Friday, August 4 by Credit Suisse. Jefferies maintained the stock with “Hold” rating in Tuesday, September 12 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: